<DOC>
	<DOCNO>NCT00698347</DOCNO>
	<brief_summary>The purpose prospective clinical data collection document performance clinical outcome M2a-Magnum™ Hip System</brief_summary>
	<brief_title>A Clinical Investigation M2a-Magnum™ Hip System</brief_title>
	<detailed_description>This 10 year prospective data collection document function survivorship M2a-Magnum™ Hip System . Patients require come preoperative , operative , one year follow-up , three year follow-up , five year follow-up , ten year follow-up exam . This product FDA clear 2004 .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<criteria>Noninflammatory degenerative joint disease include : Avascular Necrosis , Diastrophic Variant , Fracture Pelvis , Fused Hip , Leg Perthes , Osteoarthritis , Slipped Capital Epiphysis , Subcapital Fractures , Traumatic Arthritis Rheumatoid Arthritis Correction Functional Deformity Treatment nonunion , femoral neck fracture , trochanteric fracture proximal femur head involvement , unmanageable technique Revision previously fail total hip arthroplasty Absolute contraindication include : Infection , Sepsis , Osteomyelitis Relative contraindication include : Uncooperative patient patient neurologic disorder incapable follow direction Osteoporosis Metabolic disorder may impair bone formation Osteomalacia Distant focus infection may spread implant site Rapid joint destruction , mark bone loss , bone resorption apparent roentgenogram Vascular insufficiency , muscular atrophy , neuromuscular disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Total Knee Replacement</keyword>
	<keyword>Total Knee Arthroplasty</keyword>
	<keyword>Hip Arthritis</keyword>
</DOC>